FDA Approves Juvmo (tavapadon) for the Treatment of Parkinson's Disease

Sep 29, 2026 - 04:00
 0  1
NORTH CHICAGO, Ill., Sept. 28, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Juvmo (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0